Table 1.
Characteristics and epidemiological summary of study participants
| Cohort demographics | Reactive (n = 113) |
Non-reactive (n = 178) |
Overall (n = 291) |
|||
|---|---|---|---|---|---|---|
| Residents | Staff | Residents | Staff | Residents | Staff | |
| N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | |
| Total cases | 68 | 45 | 54 | 124 | 122 | 169 |
| Facility | ||||||
| Facility A | 31 (46) | 23 (51) | 5 (9) | 48 (39) | 36 (30) | 71 (42) |
| Facility B | 37 (54) | 22 (49) | 49 (91) | 76 (61) | 86 (70) | 98 (58) |
| Age (y) | ||||||
| Median (IQR) | 86 (14) | 50 (20) | 86 (14) | 49 (18) | 86 (15) | 49 (18) |
| Sex | ||||||
| Female | 51 (75) | 32 (71) | 33 (61) | 94 (76) | 84 (69) | 126 (75) |
| Male | 17 (25) | 13 (29) | 21 (39) | 30 (24) | 38 (31) | 43 (25) |
| Symptomatic | ||||||
| Symptoms reported | 58 (85) | 37 (82) | 22 (41) | 39 (31) | 80 (66) | 76 (45) |
| No symptoms reported | 10 (15) | 8 (18) | 32 (59) | 85 (69) | 42 (34) | 93 (55) |
| NAAT result | ||||||
| Positive | 50 (74) | 30 (67) | 0 (0) | 0 (0) | 50 (41) | 30 (18) |
| Negative | 9 (13) | 7 (16) | 51 (94) | 84 (68) | 60 (49) | 91 (54) |
| No Result* | 9 (13) | 8 (18) | 3 (6) | 40 (32) | 12 (10) | 48 (28) |
| Immunocompromised | ||||||
| Yes | 14 (21) | 1 (2) | 7 (13) | 1(1) | 21 (17) | 2 (1) |
⁎
Indicates that no specimen was collected to be sent for NAAT.